Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

18
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
18
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

85
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
85
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Goal-concordant care for older adults with advanced heart failure: A retrospective cohort study.

Palliative medicine·2026
Same author

Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.

Nature medicine·2026
Same author

Weight loss, exercise haemodynamics, and health status with incretin therapy for heart failure with preserved ejection fraction and obesity.

European heart journal·2026
Same author

Multidisciplinary approach to implementing ferric carboxymaltose for IV iron replacement in heart failure with iron deficiency.

Future cardiology·2026
Same author

Toward Phenotype-Stratified Perioperative Cardiac Risk Prediction.

European journal of preventive cardiology·2026
Same author

Implementation of a Digital Patient Activation Tool to Engage Patients With Heart Failure in Intensification of Guideline-Directed Medical Therapies.

Computers, informatics, nursing : CIN·2026

Related Experiment Video

Updated: Jul 12, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.5K

Palliative Care for Patients With Heart Failure With Preserved Ejection Fraction.

Sarah Godfrey1, Yilong Peng2, Nicholas Lorusso3

  • 1Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (S.G., M.S., A.P.).

Circulation. Heart Failure
|October 23, 2023
PubMed
Summary

Palliative care (PC) can improve quality of life for heart failure with preserved ejection fraction (HFpEF) patients, but PC referrals remain low. Addressing barriers is crucial for better HFpEF care outcomes.

Keywords:
heart failuremorbidityprognosisquality of lifeuncertainty

More Related Videos

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

1.9K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.5K

Related Experiment Videos

Last Updated: Jul 12, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.5K
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

1.9K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.5K

Area of Science:

  • Cardiology
  • Geriatrics
  • Palliative Care

Background:

  • Heart failure with preserved ejection fraction (HFpEF) is the predominant form of heart failure globally, especially in older adults.
  • HFpEF significantly contributes to patient morbidity and mortality, similar to heart failure with reduced ejection fraction.
  • Palliative care (PC) has demonstrated benefits in quality of life and healthcare utilization for heart failure patients.

Purpose of the Study:

  • To examine the role and timing of palliative care (PC) integration in heart failure with preserved ejection fraction (HFpEF) management.
  • To identify barriers hindering PC referrals and explore potential benefits for HFpEF patients.

Main Methods:

  • Review of existing palliative care trials in heart failure, noting the lack of HFpEF-specific data.
  • Analysis of identified barriers to PC referral in HFpEF populations.
  • Exploration of potential patient-centered outcomes associated with PC.

Main Results:

  • PC referral rates for HFpEF are notably low.
  • Significant barriers include limited data, prognostic uncertainty, provider misconceptions, workforce shortages, and treatment complexities.
  • Despite barriers, PC offers potential benefits for HFpEF patients across the disease trajectory.

Conclusions:

  • Palliative care integration into HFpEF care is currently limited but holds significant potential.
  • Targeted research and implementation strategies are essential to improve quality of life and end-of-life care for the growing HFpEF population.